{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:15:46Z","timestamp":1792880146949,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.diabres.2014.09.056","type":"journal-article","created":{"date-parts":[[2014,10,25]],"date-time":"2014-10-25T12:15:32Z","timestamp":1414239332000},"page":"504-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effects of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: Association with BNP and aldosterone levels"],"prefix":"10.1016","volume":"106","author":[{"given":"Masami","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Sekioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiro","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2014.09.056_bib0005","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1097\/00005344-198900131-00003","article-title":"Risk factors in hypertension","volume":"13","author":"Kannel","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.diabres.2014.09.056_bib0010","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1291\/hypres.19.SupplementI_S1","article-title":"Insulin resistance and hypertension in Japanese","volume":"19","author":"Iimura","year":"1996","journal-title":"Hypertens Res"},{"key":"10.1016\/j.diabres.2014.09.056_bib0015","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1291\/hypres.29.839","article-title":"Sympathetic overdrive and cardiovascular risk in the metabolic syndrome","volume":"29","author":"Grassi","year":"2006","journal-title":"Hypertens Res"},{"key":"10.1016\/j.diabres.2014.09.056_bib0020","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.metabol.2012.09.005","article-title":"Exercise improves cardiac autonomic function in obesity and diabetes","volume":"62","author":"Voulgari","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.diabres.2014.09.056_bib0025","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/MED.0b013e3282f7026f","article-title":"The renin\u2013angiotensin\u2013aldosterone system: a pivotal role in insulin sensitivity and glycemic control","volume":"15","author":"Perkins","year":"2008","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.diabres.2014.09.056_bib0030","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1097\/01.hjh.0000220407.84363.fb","article-title":"Angiotensin-sympathetic system interactions in cardiovascular and metabolic disease","volume":"24","author":"Mancia","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/j.diabres.2014.09.056_bib0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/hr.2009.34","article-title":"The Japanese Society of hypertension guidelines for the management of hypertension (JSH 2009)","volume":"32","author":"Ogihara","year":"2009","journal-title":"Hypertens Res"},{"key":"10.1016\/j.diabres.2014.09.056_bib0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1755-5922.2009.00079.x","article-title":"Cilnidipine: a new generation Ca channel blocker with inhibitory action on sympathetic neurotransmitter release","volume":"27","author":"Takahara","year":"2009","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.diabres.2014.09.056_bib0045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000210396","article-title":"Different effects of L\/N-type and L-type calcium channel blockers on the renin\u2013angiotensin\u2013aldosterone system in SHR\/Izm","volume":"30","author":"Konda","year":"2009","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.diabres.2014.09.056_bib0050","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1097\/HJH.0b013e32833d01dd","article-title":"A new-generation N\/L-type calcium channel blocker leads to less activation of the renin\u2013angiotensin system compared with conventional L type calcium channel blocker","volume":"28","author":"Konoshita","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.diabres.2014.09.056_bib0055","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/147323001003800222","article-title":"The L\/N-type calcium channel blocker, cilnidipine, reduces heart rate and albuminuria in patients with type 2 diabetes","volume":"38","author":"Tanaka","year":"2010","journal-title":"J Int Med Res"},{"key":"10.1016\/j.diabres.2014.09.056_bib0060","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1248\/bpb.29.933","article-title":"Effects of L\/N-type calcium channel antagonist, cilnidipine on progressive renal injuries in Dahl salt-sensitive rats","volume":"29","author":"Konda","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.diabres.2014.09.056_bib0065","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0168-8227(99)00053-4","article-title":"Cilnidipine, the N- and L-type calcium antagonist, reduced on 24-h urinary catecholamines and C-peptide in hypertensive non-insulin-dependent diabetes mellitus","volume":"44","author":"Takeda","year":"1999","journal-title":"Diabetes Res Clin Pract"},{"issue":"May (4)","key":"10.1016\/j.diabres.2014.09.056_bib0070","first-page":"169","article-title":"Can plasma catecholamine levels be a useful index of sympathetic nervous system activity?","volume":"4","author":"Fernandez","year":"1988","journal-title":"Can J Cardiol"},{"issue":"3","key":"10.1016\/j.diabres.2014.09.056_bib0075","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1183\/09031936.02.00106402","article-title":"Obstructive sleep apnoea and urine catecholamines in hypertensive males: a population-based study","volume":"19","author":"Elmasry","year":"2002","journal-title":"Eur Respir J"},{"key":"10.1016\/j.diabres.2014.09.056_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jphs.10R07CR","article-title":"Pathophysiological roles of aldosterone and mineralocorticoid receptor in the kidney","volume":"115","author":"Rafiq","year":"2011","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.diabres.2014.09.056_bib0085","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/hr.2010.191","article-title":"Expression of N-type calcium channels in human adrenocortical cells and their contribution to corticosteroid synthesis","volume":"34","author":"Aritomi","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.diabres.2014.09.056_bib0090","first-page":"155","article-title":"Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure","volume":"45","author":"Kyuma","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.diabres.2014.09.056_bib0095","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/CS20080390","article-title":"Role of the renin\u2013angiotensin\u2013aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction","volume":"116","author":"Sciarretta","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.diabres.2014.09.056_bib0100","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/sj.ki.5002623","article-title":"Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin\u2013angiotensin inhibition in hypertensive patients with chronic renal disease","volume":"72","author":"Fujita","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2014.09.056_bib0105","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.ki.5000349","article-title":"Comparison between valsartan and valsartan plus cilnidipine in type II diabetics with normo- and microalbuminuria","volume":"70","author":"Katayama","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.diabres.2014.09.056_bib0110","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1536\/ihj.49.723","article-title":"Vasodilatory effect of cilnidipine, an L-type and N-type calcium channel blocker, on rat kidney glomerular arterioles","volume":"49","author":"Konno","year":"2008","journal-title":"Int Heart J"},{"key":"10.1016\/j.diabres.2014.09.056_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000085713","article-title":"The N- and L-type calcium channel blocker cilnidipine suppresses renal injury in Dahl rats fed a high-sucrose diet, an experimental model of metabolic syndrome","volume":"101","author":"Konda","year":"2005","journal-title":"Nephron Physiol"},{"key":"10.1016\/j.diabres.2014.09.056_bib0120","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2337\/dc10-1392","article-title":"Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients","volume":"34","author":"Kamijo-Ikemori","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2014.09.056_bib0125","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.2353\/ajpath.2009.080780","article-title":"Urinary excretion of liver type fatty acid binding protein accurately reflects the degree of tubulointerstitial damage","volume":"174","author":"Yokoyama","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.diabres.2014.09.056_bib0130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.ajkd.2005.10.013","article-title":"Timed urine collections are not needed to measure urine protein excretion in clinical practice","volume":"47","author":"Shidham","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.diabres.2014.09.056_bib0135","first-page":"110","article-title":"Quantitation of proteinuria in kidney transplant patients: accuracy of the urinary protein\/creatinine ratio","volume":"43","author":"Steinh\u00e4uslin","year":"1995","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.diabres.2014.09.056_bib0140","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00007890-200110270-00021","article-title":"The urine protein to creatinine ratio (P\/C) as a predictor of 24-hour urine protein excretion in renal transplant patients","volume":"72","author":"Torng","year":"2001","journal-title":"Transplantation"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822714004562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822714004562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T07:24:12Z","timestamp":1538119452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822714004562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0168822714004562"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2014.09.056","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of cilnidipine on sympathetic nerve activity and cardiorenal function in hypertensive patients with type 2 diabetes mellitus: Association with BNP and aldosterone levels","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2014.09.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}